Background The Pharmacopoeia of the People\’s Republic of China (Chinese Pharmacopoeia, or ChP) is China\’s official collection of standar…
Background Before the Cosmetic Supervision and Administration Regulation (CSAR) was released in China, only sunscreen efficacy and the waterproof effi…
As more sodium hyaluronate products emerge on the market, China is going to update its regulations to better guide the registration and supervision of…
On May 20, China National Medical Products Administration (NMPA) released the revised draft of the Announcement on the Administrative Classifications …
Background China is at the forefront of the global importation of food products. According to \”China Imported Food Industry Report 2021\”…
Background The Middle East has long been a relative patchwork of chemical substance regulations, from some countries implementing significant restrict…
In recent years, China\’s pharmaceutical industry has been developing, reforming, and innovating. As a highlight in China\’s Drug Administ…
On May 9, China National Medical Products Administration (NMPA) released the draft of the revised Regulations for Implementation of the Drug Administr…
Generic drugs comprise a significant part of China\’s pharmaceutical market. In 2020, 63% of marketed drugs in China were generics. The Chinese …
